Psychosis superspectrum I: Nosology, etiology, and lifespan development

KG Jonas, TD Cannon, AR Docherty, D Dwyer… - Molecular …, 2024 - nature.com
This review describes the Hierarchical Taxonomy of Psychopathology (HiTOP) model of
psychosis-related psychopathology, the psychosis superspectrum. The HiTOP psychosis …

Prevalence of individuals at clinical high-risk of psychosis in the general population and clinical samples: systematic review and meta-analysis

G Salazar de Pablo, SW Woods, G Drymonitou… - Brain sciences, 2021 - mdpi.com
(1) The consistency and magnitude of the prevalence of Clinical High-Risk for Psychosis
(CHR-P) individuals are undetermined, limiting efficient detection of cases. We aimed to …

Prevention of psychosis: advances in detection, prognosis, and intervention

P Fusar-Poli, GS De Pablo, CU Correll… - JAMA …, 2020 - jamanetwork.com
Importance Detection, prognosis, and indicated interventions in individuals at clinical high
risk for psychosis (CHR-P) are key components of preventive psychiatry. Objective To …

Beyond the “at risk mental state” concept: transitioning to transdiagnostic psychiatry

PD McGorry, JA Hartmann, R Spooner… - World …, 2018 - Wiley Online Library
The “at risk mental state” for psychosis approach has been a catalytic, highly productive
research paradigm over the last 25 years. In this paper we review that paradigm and …

Multimodal machine learning workflows for prediction of psychosis in patients with clinical high-risk syndromes and recent-onset depression

N Koutsouleris, DB Dwyer, F Degenhardt, C Maj… - JAMA …, 2021 - jamanetwork.com
Importance Diverse models have been developed to predict psychosis in patients with
clinical high-risk (CHR) states. Whether prediction can be improved by efficiently combining …

Clinical validity of DSM-5 attenuated psychosis syndrome: advances in diagnosis, prognosis, and treatment

GS De Pablo, A Catalan, P Fusar-Poli - JAMA psychiatry, 2020 - jamanetwork.com
Importance Since the release of theDSM-5diagnosis of attenuated psychosis syndrome
(DSM-5–APS) in 2013, several research studies have investigated its clinical validity …

Improving the detection of individuals at clinical risk for psychosis in the community, primary and secondary care: an integrated evidence-based approach

P Fusar-Poli, SA Sullivan, JL Shah… - Frontiers in psychiatry, 2019 - frontiersin.org
Background: The first rate-limiting step for improving outcomes of psychosis through
preventive interventions in people at clinical high risk for psychosis (CHR-P) is the ability to …

Pluripotential risk and clinical staging: theoretical considerations and preliminary data from a transdiagnostic risk identification approach

JA Hartmann, PD McGorry, L Destree… - Frontiers in …, 2021 - frontiersin.org
Most psychiatric disorders develop during adolescence and young adulthood and are
preceded by a phase during which attenuated or episodic symptoms and functional decline …

Wireless, noninvasive therapeutic drug monitoring system for saliva measurement toward medication management of schizophrenia

Z Yan, Z Shi, Y Wu, J Lv, P Deng, G Liu, Z An… - Biosensors and …, 2023 - Elsevier
As an efficient patient management tool of precision medicine, decentralized therapeutic
drug monitoring (TDM) provides new vision for therapy adherence and health management …

MicroRNAs in the Onset of Schizophrenia

KT Thomas, SS Zakharenko - Cells, 2021 - mdpi.com
Mounting evidence implicates microRNAs (miRNAs) in the pathology of schizophrenia.
These small noncoding RNAs bind to mRNAs containing complementary sequences and …